MDPI and ACS Style
Mastorino, L.; Dapavo, P.; Cariti, C.; Susca, S.; Siliquini, N.; Ortoncelli, M.; Stroppiana, E.; Verrone, A.; Giunipero di Corteranzo, I.; Leo, F.;
et al. Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. J. Pers. Med. 2024, 14, 718.
https://doi.org/10.3390/jpm14070718
AMA Style
Mastorino L, Dapavo P, Cariti C, Susca S, Siliquini N, Ortoncelli M, Stroppiana E, Verrone A, Giunipero di Corteranzo I, Leo F,
et al. Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of Personalized Medicine. 2024; 14(7):718.
https://doi.org/10.3390/jpm14070718
Chicago/Turabian Style
Mastorino, Luca, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo,
and et al. 2024. "Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience" Journal of Personalized Medicine 14, no. 7: 718.
https://doi.org/10.3390/jpm14070718
